Models including serum CA-125, BMI, cyst pathology, dysmenorrhea or dyspareunia for diagnosis of endometriosis

Biomark Med. 2018 Jul;12(7):737-747. doi: 10.2217/bmm-2017-0426. Epub 2018 Jun 5.

Abstract

Aim: To evaluate preoperative levels of CA-125 and HE4 in patients with endometriosis-like symptoms and to construct diagnostic models.

Patients: Prospective case-control study included 124 endometriosis patients and 97 control patients.

Materials & methods: Logistic regression was used to construct diagnostic models based on serum biomarker levels and clinical data.

Results: A model with CA-125, BMI, information on cysts and dyspareunia had an area under the curve value of 0.836, sensitivity of 74.0% and specificity of 81.3%. The second model included CA-125, BMI, information on cysts and dysmenorrhea and had an area under the curve value of 0.819, sensitivity of 74.8% and specificity of 79.2%.

Conclusion: Constructed models have the potential for noninvasive diagnosis of endometriosis, and might be translated into clinical practice after additional validation.

Keywords: CA-125; HE4; diagnostic algorithm; endometriosis; fallopian tubes; logistic regression; ovarian cysts.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Body Mass Index*
  • CA-125 Antigen / blood*
  • Case-Control Studies
  • Cysts / complications*
  • Dysmenorrhea / complications*
  • Dyspareunia / complications*
  • Endometriosis / blood
  • Endometriosis / complications
  • Endometriosis / diagnosis*
  • Endometriosis / pathology
  • Fallopian Tubes / pathology
  • Female
  • Humans
  • Models, Statistical*
  • Pain / complications
  • Proteins / metabolism
  • WAP Four-Disulfide Core Domain Protein 2

Substances

  • CA-125 Antigen
  • Proteins
  • WAP Four-Disulfide Core Domain Protein 2
  • WFDC2 protein, human